This site is intended for healthcare professionals
Drug news

NICE to recommend Botox (Allergan) for Migraine

Read time: 1 mins
Last updated:11th May 2012
Published:11th May 2012
Source: Pharmawand
NICE,the health technology appraisal institute for England and Wales, will now recommend Botox (botulinum toxin type A) injections from Allergan, as a preventative treatment for Chronic Migraine, in its final draft guidance. NICE was undecided about the drug and one area of concern was that the data supporting Botox were confounded by a large placebo effect. Allergan have provided more data and now Botox could soon become a NHS treatment option to prevent headaches in adults who experience Chronic Migraine.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.